Sat. November 21, 2009
-
Reuters
November 20, 2009
... mutation had any implication for the effect of
flu vaccines or antiviral drugs made by groups such as Roche,
GlaxoSmithKline ,
Novartis or
AstraZeneca. ...
PRWeek UK
November 20, 2009
Red Health has supported
Novartis Oncology in launching an initiative to help improve media reporting of
breast cancer. The report 'Achieving Excellence in ...
Reuters
November 20, 2009
L) Pandemrix or
Novartis's (NOVN.VX) Focetria
swine flu vaccines would suffice for most people. The European Medicines Agency (EMEA) had previously said two ...
Zenopa
November 20, 2009
Novartis has revealed the results of a study this week, which showed that just half of its vaccine dose for the H1N1 strain could serve to fully protect ...
Daily News & Analysis
November 19, 2009
Dan Vasella, the chief executive of Swiss firm
Novartis, which has been struggling for the last five years to secure the patent rights in
India on Glivec, ...
Motley Fool
November 19, 2009
Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article.
Novartis is a Motley Fool
global Gains selection. ...
GuruFocus.com
November 19, 2009
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership ...
Trading Markets (press release)
November 19, 2009
The payment has been triggered by successful delivery to Novartis of Nanobody candidates which met specific criteria. This will be the third milestone ...
Reuters
November 19, 2009
Roche and
Novartis's asthma drug Xolair should not be approved for
children aged 6 to 11, a US advisory panel decided on
Wednesday. ...
MarketWatch
November 19, 2009
Switzerland's
Novartis AG (
NYSE:NVS) , which acquired a local maker of generic drugs in 2005, is currently the only major foreign pharmaceutical firm ...
abc7news.com
November 19, 2009
More than seven million doses of
swine flu vaccine have been ordered from drug maker
Novartis. WASHINGTON (KGO) -- The Food and Drug Administration has ...
Motley Fool
November 18, 2009
Novartis is a
global Gains pick. Try any of our Foolish newsletters today, free for 30 days. Fool contributor Brian Orelli, Ph.D., doesn't own shares of any ...
Trading Markets (press release)
November 18, 2009
This is the second business agreement between Horizon and
Novartis and and sees the use of Horizon's proprietary GENESIS(TM) gene-
engineering platform to ...
WTVG
November 18, 2009
Preliminary results from manufacturer
Novartis show a lower dose of its vaccine may be enough to give immunity from the
swine flu virus. ...
Reuters
November 18, 2009
VX) and
Novartis's (NOVN.VX) asthma drug Xolair should not be used in
children aged 6 to 11, a US advisory panel voted on
Wednesday. ...
Reuters
November 18, 2009
... that were overcome, was a significant accomplishment for the
US government and
Novartis Vaccines partnership," added Dr Vas Narasimhan of
Novartis. ...
dBusinessNews Chicago (press release)
November 18, 2009
Novartis Animal Health donates one-year supply of combination heartworm, intestinal worm, and flea medication to each member of the Canine Unit treated by ...
Malaysia Star
November 18, 2009
KUALA LUMPUR:
global drug company
Novartis AG and the
Sarawak Biodiversity Council (SBC) have sealed a formal pact to jointly develop novel bioactive ...
DailyTech
November 18, 2009
Swiss biotech company Novartis discovered that a half dose of its A(H1N1) 2009 unadjuvanted vaccine may help the person receiving the shot to develop a ...
Motley Fool
November 17, 2009
Novartis AG is a
global Gains selection. The Fool owns shares of Berkshire Hathaway. The Fool's disclosure policy had a bad vodka experience once, ...
Reuters
November 16, 2009
VX) and
Novartis (NOVN.VX) has "somewhat modest" benefits for
children aged 6 to 11, US reviewers said in documents released on
Monday. ...
Reuters
November 13, 2009
Belgrade, Nov 13 (Reuters) -
Serbia on
Friday signed a contract for the purchase of 3 million doses of new
flu vaccinces from Swiss
Novartis AG (NOVN. ...
On the other side, arguing that the lower court standard is too restrictive, are New York-based
American Express;
Minneapolis-based Medtronic Inc.;
Novartis ...
On the other side, arguing that the lower court standard is too restrictive, are New York-based
American Express;
Minneapolis-based Medtronic Inc.;
Novartis ...
One,
Switzerland-based
Novartis, initially was able to grow only 23 percent of the virus it normally expected to get from a typical
flu vaccine. ...
Basel-based Roche is suspected of helping multinational companies including HSBC and
Novartis buy big amounts of Tamiflu in
South Korea, ...
Basel-based Roche is suspected of helping multinational companies including HSBC and
Novartis buy big amounts of Tamiflu in
South Korea, ...
The income in 2009 is attributable to the agreement with Novartis and a reduction of costs associated with the Phase IIb clinical trial of Tovaxin that was ...
The income in 2009 is attributable to the agreement with Novartis and a reduction of costs associated with the Phase IIb clinical trial of Tovaxin that was ...
The income in 2009 is attributable to the agreement with Novartis and a reduction of costs associated with the Phase IIb clinical trial of Tovaxin that was ...
MedPage Today
November 5, 2009
The study was supported by Novartis
路透中国
November 5, 2009
Novartis
Woodlands Online, LLC
November 5, 2009
The income in 2009 is attributable to the agreement with Novartis
GuruFocus.com
November 5, 2009
As part of the Novartis
Pharmaceutical Technology Magazine
November 5, 2009
Novartis
Alibaba News Channel
November 5, 2009
ZURICH, Nov 4 - Swiss drugmaker Novartis
Seeking Alpha (blog)
November 5, 2009
Novartis
ZURICH --
Novartis AG said
Wednesday it plans to buy a majority stake in privately held Chinese vaccines maker
Zhejiang Tianyuan for around ...
ZURICH --
Novartis AG said
Wednesday it plans to buy a majority stake in privately held Chinese vaccines maker
Zhejiang Tianyuan for around ...
